CASE STUDY

Eli Lilly Laboratory Redesign

CHALLENGE

Current research laboratory spaces are not designed to meet 21st century demands of its scientists. The labs’ outdated facilities isolate individuals and make their work less efficient. This results in limited scientific progress, stifles collaboration and limits personal and organizational growth.

“We don’t want another red brick building that’s represented by a number. We want a building that
will elicit creativity and a field for collaboration.”

2012-09-21 00.39.46.jpg
2012-09-21 20.49.42.jpg
2012-09-21 21.42.18.jpg
2012-09-23 00.54.11.jpg
Lilly%2BLab%2Bimages%2Bfinal%2Bprez%2B73.jpg
Lilly Lab images final prez 42.jpg

DISCOVERY

1. Who are all of our stakeholders?

2. How do laboratories look now and how are they used?

3. Engage all stakeholders in the discovery process.

LEARNING AND INSIGHTS

How might we…

labs around the science and
the scientists
to drive personal & organizational productivity?

How will we do this?

1. My space:
Hods, halls, and workspaces

2. My potential:
Workflow and connectivity

4. Our organization:
Portfolio and Patients

Leverage internal knowledge and partnerships to drive more patient-centered and portfolio-enhancing processes.

better equip scientists with 21st century connectivity to drive progress?

foster collaboration throughout the organization?

3. Our collaboration:
Serendipitous and planned

“Talking to patients would be Holy Grail. Today, we just have market research.”

RESULT

We delivered comprehensive documentation of our research, recommendations, and a guideline of
strategy for implementation.

In 2015, Eli Lilly announced the headquarters expansion investing over $70 million into the project.

OUTCOMES

After completion in 2017…

Collaboration-centric workspaces
Organic chemists and engineers work side-by-side with modeling, analytical and formulation scientists.

Flexible laboratories
Labs adapt as research and technology needs evolve,
as well as open, interactive meeting spaces meant to spark creativity and multi-disciplinary problem-solving.

Innovation
Spaces allow for greater collaboration among Lilly’s small molecule research experts, which will help to accelerate the development of new medicines within the company’s core therapeutic areas.